Bizzari Jean-Pierre Insider Trades

Insider Trading History

Track insider trading activity for Bizzari Jean-Pierre. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $141k 106,902 shares
Last Trade
Jun 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.1k 12,600 shares
$3.58
$1.32
Aprea Therapeutics
Aprea Therapeutics APRE
Director
Holding Value $3.24k 4,185 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.78
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $158k 119,502 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 40,000 shares
$3.59
$1.32
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $105k 79,502 shares
Last Trade
Jun 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.2k 6,995 shares
$2.89
$1.32
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $114k 86,497 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 40,000 shares
$3.16
$1.32
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $61.4k 46,497 shares
Last Trade
Jan 02, 2024 Sale
$52.3k 30,937 shares
$1.69
$1.32
Aprea Therapeutics
Aprea Therapeutics APRE
Director
Holding Value $9.69k 12,500 shares
Last Trade
Aug 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.6k 12,500 shares
$3.65
$0.78
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $4.78M 66,815 shares
Last Trade
May 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 11,371 shares
$31.00
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $4.21M 58,750 shares
Last Trade
May 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 6,206 shares
$40.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.76M 52,544 shares
Last Trade
Aug 25, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.44M 35,000 shares
$41.01
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $6.27M 87,544 shares
Last Trade
May 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 5,230 shares
$47.81
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $5.89M 82,314 shares
Last Trade
Apr 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 8,829 shares
$22.66
$71.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17M 20,000 shares
$258.40
$13.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $5.26M 73,485 shares
Last Trade
May 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 12,173 shares
$16.43
$71.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.38M 20,000 shares
$219.20
$13.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $4.39M 61,312 shares
Last Trade
May 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 10,363 shares
$19.30
$71.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.4M 20,000 shares
$617.60
$13.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $3.65M 50,949 shares
Last Trade
May 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 14,135 shares
$14.15
$71.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22M 20,000 shares
$160.80
$13.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.64M 36,814 shares
Last Trade
May 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 20,202 shares
$9.90
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up